Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
[Pharmacological treatment of spasticity in multiple sclerosis].
Cognitive assessment in MS.
Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis.
Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies.
The Persian Version of Community Integration Questionnaire in persons with multiple sclerosis: translation, reliability, validity, and factor analysis.
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics.
Fingolimod effect on brain volume loss independently contributes to its effect on disability.
Falls and physical activity in persons with multiple sclerosis.
Advancing therapeutic options in multiple sclerosis with neuroprotective properties.
Obstetrical epidural and spinal anesthesia in multiple sclerosis.
Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.
Onset of secondary progressive phase and long-term evolution of multiple sclerosis.
R PheWAS: Data Analysis and Plotting Tools for Phenome Wide Association Studies in the R Environment.
Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist.
Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
Oligodendrocyte-Specific Activation of PERK Signaling Protects Mice against Experimental Autoimmune Encephalomyelitis.
Methods for the detection of peptidylarginine deiminase activity and protein citrullination.
Radiologically isolated syndrome - incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review.
Extended interval dosing of natalizumab: a two-center, 7-year experience.
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex.
Multiple sclerosis: Characterization of lesion evolution in relapsing-remitting and secondary progressive multiple sclerosis.
Determinants of central nervous system adult neurogenesis are sex, hormones, mouse strain, age, and brain region.
Pages
« first
‹ previous
…
230
231
232
233
234
235
236
237
238
…
next ›
last »